SAN JOSE, Calif., May 11, 2023 - icotec has joined the RSS Sponsorship Alliance, adding to the list of highly respected corporations, institutions, organizations and societies to support the advancement of stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT) and advancing therapies.
With the mission of expanding treatment options and allowing for safer spine tumor care, icotec develops, and markets spinal implants made from radiolucent and artifact-free BlackArmor® Carbon/PEEK. "We are excited to join the RSS Sponsorship Alliance to help bridge disciplines and foster multidisciplinary care for spine tumor patients worldwide,” stated Carter Lonsberry, CEO of icotec Medical, Inc.
"The use of the icotec spinal implant products have significantly improved complex spinal SBRT not only in treatment planning and delivery of post-operative adjuvant SBRT, but also in the imaging follow-up to assess the patient's response to therapy," commented John J. Kresl, MD, FASTRO, FACRO, FACR, DABR.
icotec is a family-owned company from Switzerland. icotec’s proprietary BlackArmor® material is made up of continuous carbon fibers combined with PEEK and is processed with a unique manufacturing technology. With 20 years of clinical success and more than 50,000 implanted products, icotec is a pioneer in cutting-edge spinal tumor therapy.
The RSS welcomes sponsoring organizations as partners in the RSS Sponsorship Alliance. These organizations champion the evolution of science and research clinical practices, patient safety and efficacy, technological innovations and global adoption of SRS/SBRT techniques. Sponsors join the ranks of highly-respected institutions, organizations, societies and corporations to support successful advancements in the field.
The Radiosurgery Society® is an international, medical professional, non-profit society consisting of physicians, physicists and healthcare professionals dedicated to advancing the education, science and clinical practice of stereotactic radiosurgery, stereotactic body radiation therapy and advancing therapies.
Contacts:
Stephanie Tomei
the Radiosurgery Society®
PressRelease@therss.org